Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Rebif

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Rebif was produced by Merck KGaA.

Merck Serono to invest €150m in China R&D

The Swiss-based company's key products Erbitux (cancer), Rebif (multiple sclerosis), Gobal-f (infertility), Saizen (endocrine and metabolic disorders) and Concor and Euthyrox (cardiometabolic diseases) are already available in the

Absorb the impact

Therapeutic area. How it works. Comments. Performance-based schemes. Betaferon (Schering), Avonex (Biogen), Rebif (Merck Serono), Copaxone (Teva/Aventis).

MS treatment hopes

Clinicians may recommend one of three interferons (Biogen Idec's Avonex or EMD Serono/Pfizer's Rebif, which are both formulations of interferon ß-1a, or Bayer's Betaseron, an interferon

Pharma news in brief

Previously, doctors could only prescribe Rebif if patients had had two attacks - they can now do so if patients have had just one attack. ... Rebif had sales of $1.3bn, about half of Serono's overall sales.

Buzz grows over Serono auction

As a proposition, family-controlled Serono has managed to create a comfortable niche for itself with Rebif, its successful multiple sclerosis treatment. ... Rebif, which in 2004 accounted for nearly 50 per cent of total sales.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics